Tatva Chintan Pharma - Quaterly Results

28 Jan 2025 Evaluate
Revenue reduced marginally to stand at Rs. 839.99 millions during the quarter ended December 2024. The figure stood at Rs. 860.69 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -11.65 millions as compared to Net Profit of Rs. 46.51 millions of corresponding quarter ended December 2023Operating Profit reported a sharp decline to 56.86 millions from 135.22 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 839.99 860.69 -2.41 2587.67 2847.47 -9.12 3786.77 4030.44 -6.05
Other Income 0.40 12.09 -96.69 22.66 29.80 -23.96 75.08 56.78 32.23
PBIDT 56.86 135.22 -57.95 202.07 556.47 -63.69 743.73 603.56 23.22
Interest 4.16 3.77 10.34 9.02 62.89 -85.66 65.07 83.84 -22.39
PBDT 52.70 131.45 -59.91 193.05 493.58 -60.89 678.66 483.85 40.26
Depreciation 69.23 65.82 5.18 203.98 193.69 5.31 256.01 95.54 167.96
PBT -16.53 65.63 -125.19 -10.93 299.89 -103.64 422.65 388.31 8.84
TAX -4.88 19.12 -125.52 -3.25 88.87 -103.66 129.17 -16.34 -890.51
Deferred Tax -4.32 5.91 -173.10 -3.41 36.70 -109.29 55.74 -35.93 -255.13
PAT -11.65 46.51 -125.05 -7.68 211.02 -103.64 293.48 404.65 -27.47
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 221.65 5.54
PBIDTM(%) 6.77 15.71 -56.91 7.81 19.54 -60.04 19.64 14.98 31.15

Tatva Chintan Pharma Share Price

1326.00 -10.70 (-0.80%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3910.45
Tata Chemicals 751.25
SRF 3058.90
Pidilite Inds. 1469.10
Deepak Nitrite 1702.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×